Ascendis Pharma A ASND SEC Filings

NASDAQ ASND
$268.17 -2.95 (-1.09%)
As of: Sep 4, 2026 · 1:31 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Ascendis Pharma A/S (ASND) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index